Dive Brief:
- Johnson & Johnson could be selling its artificial sweetener Splenda with the help of Goldman Sachs, say unnamed sources to Reuters. Potential buyers are in the mix, but it is still in the early stages.
- J&J and Goldman Sachs both declined responses, according to Reuters.
- Splenda was created in conjunction with J&J branch Tate & Lyle, the company's current sucralose provider. Tate also declined comment.
Dive Insight:
Reuters notes that in markets like the United States, the thirst for carbonated soft drinks has fallen, but natural sweeteners are now stirring more discussion. One can't forget about Pepsi True and Coca-Cola Life, after all.
